Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1357.20
18.70 (1.40%)
< Home < Back

Dr Reddy's Laboratories informs about press release

Date: 03-02-2022

Dr Reddy's Laboratories has informed that it enclosed a Press Release on ‘Dr. Reddy's Laboratories enters into Definitive Agreement to acquire German medical cannabis firm Nimbus Health GmbH’.

The above information is a part of company’s filings submitted to BSE.